2 years ago
BMS Breyanzi FDA Approval History
BMS Breyanzi FDA Approval History Breyanzi Introduction Breyanzi (lisocabtagene maraleucel), a CD19-directed chimeric antigen receptor T cell (CAR-T) therapy, developed by Bristol Myers Squibb (BMS...